Genotyping Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genotyping stocks.

Genotyping Stocks Recent News

Date Stock Title
Nov 20 ILMN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
Nov 20 A Agilent Technologies increases dividend by ~5% to $0.248
Nov 20 A Agilent Increases Cash Dividend to 24.8 Cents per Share
Nov 20 ILMN If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer
Nov 20 ILMN Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)
Nov 20 A Stay Ahead of the Game With Agilent (A) Q4 Earnings: Wall Street's Insights on Key Metrics
Nov 20 A Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye
Nov 20 ILMN Illumina gear up to expand TruSight Oncology portfolio
Nov 20 ILMN ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio
Nov 19 A Agilent Ranks No. 11 on Fortune’s List of Best Workplaces in the World
Nov 19 ILMN Illumina announces expansion of TruSight Oncology portfolio
Nov 19 LH Labcorp gets new finance chief
Nov 19 LH Labcorp CFO Glenn Eisenberg Announces Plans to Retire
Nov 18 ILMN Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?
Nov 16 A Agilent Technologies' (NYSE:A) earnings growth rate lags the 11% CAGR delivered to shareholders
Nov 15 ILMN Life sciences stocks viewed positively at TD Cowen despite post-election weakness
Nov 15 A Life sciences stocks viewed positively at TD Cowen despite post-election weakness
Nov 15 LH Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
Nov 14 A Al Gore's Strategic Moves in Q3 2024: Spotlight on Agilent Technologies with a 2.1% Portfolio Impact
Genotyping

Genotyping is the process of determining differences in the genetic make-up (genotype) of an individual by examining the individual's DNA sequence using biological assays and comparing it to another individual's sequence or a reference sequence. It reveals the alleles an individual has inherited from their parents. Traditionally genotyping is the use of DNA sequences to define biological populations by use of molecular tools. It does not usually involve defining the genes of an individual.
Current methods of genotyping include restriction fragment length polymorphism identification (RFLPI) of genomic DNA, random amplified polymorphic detection (RAPD) of genomic DNA, amplified fragment length polymorphism detection (AFLPD), polymerase chain reaction (PCR), DNA sequencing, allele specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or beads. Genotyping is important in research of genes and gene variants associated with disease. Due to current technological limitations, almost all genotyping is partial. That is, only a small fraction of an individual’s genotype is determined, such as with (epi)GBS (Genotyping by sequencing) or RADseq. New mass-sequencing technologies promise to provide whole-genome genotyping (or whole genome sequencing) in the future.
Genotyping applies to a broad range of individuals, including microorganisms. For example, viruses and bacteria can be genotyped. Genotyping in this context may help in controlling the spreading of pathogens, by tracing the origin of outbreaks. This area is often referred to as molecular epidemiology or forensic microbiology.
Humans can also be genotyped. For example, when testing fatherhood or motherhood, scientists typically only need to examine 10 or 20 genomic regions (like single-nucleotide polymorphism (SNPs)), which represent a tiny fraction of the human genome.
When genotyping transgenic organisms, a single genomic region may be all that needs to be examined to determine the genotype. A single PCR assay is typically enough to genotype a transgenic mouse; the mouse is the mammalian model of choice for much of medical research today.

Browse All Tags